The Singularity Prophets
By Benjamin Charles Germain Lee,
Current Affairs
| 07. 23. 2020
The Singularity’s not coming to save us, but that doesn’t stop the world’s worst people from trying to bring it about.
Ray Kurzweil, popularizer of the Singularity
Once the dust settles, and we look back on the decade that has just ended, my guess is that we will come to see the countless post-Y2K promises of artificial intelligence and machine learning for what they really were: immensely successful if you go by Bloomberg tickers and ad engagement, but empty in delivering on their utopian promises. Google promised to democratize information access. Instead, its algorithms reinforced the marginalization of women and people of color, and it mostly functioned to upsell rather than enlighten. Engineers at YouTube built a personalized recommendation algorithm that has dramatically increased watch times, but has also radicalized people with fringe content and traumatized children with creepy, violent, and scatological videos. Workers on Amazon’s Mechanical Turk platform became the unseen labor force of the machine learning revolution by annotating training data in exchange for wages no one could possibly hope to live on. (A median wage of $2.75 hourly, with only 4% of workers earning over $7, rates that are theoretically unlawful but of course aren’t thanks to the...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...